Crystal structure of 3-methyl-2-oxo-2H-chromen-7-yl propionate, C13H12O4

Abstract C13H12O4, triclinic, P1̄ (no. 2), a = 6.141(5) Å, b = 8.108(6) Å, c = 12.234(9) Å, α = 79.257(12)°, β = 76.820(12)°, γ = 74.687(11)°, V = 566.8(7) Å3, Z = 2, R gt(F) = 0.0515, wR ref(F 2) = 0.1575, T = 296(2) K

Characterization and mechanisms of lipid metabolism in high-fat diet induced hyperlipidemia in Mongolian gerbil (Meriones unguiculatus)

Rodent are common animal models for hyperlipidemia. In the present study, the differences in lipid  metabolism between gerbils and rats were investigated. Feeding a high-fat diet led to a significant increase in serum total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDLC) and high-density  lipoprotein cholesterol (HDLC) in gerbils, and were found in a time-dependent manner during 0 to 16 weeks’  feeding. Hepatic lipid vacuolization and even fibrosis in gerbils were greatly formed in response to the high fat diet with the characteristic of serum LDLC increase, while those remained lower changed or unchanged in  rats. Furthermore, serum lecithin cholesterol acyl transferase (LCAT) activities in the hyperlipidemia gerbils were significantly higher than those in the normal ones, which were also in line with increased LDLC-TG  secretion rate and impaired hepatic function in gerbils in response to the high-fat diet. Therefore, gerbils were considered to be more sensitive to high fat diet, less time-consuming in forming hyperlipidemia. Similar response in increased LDLC levels to cholesterol as human and may warrant further application as a possible model for drug evaluation and lipid metabolism.Key words: Mongolian gerbil, hypercholesterolemia, low-density lipoprotein cholesterol, lecithin cholesterol acyl transferase

The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy

It is well known that the activation of Aurora A/B (Aur A/B) or inactivation of BRCA1/2 induces tumor formation. Others and we have reported that the mutual suppression between Aur A/B and BRCA1/2 may manipulate cancer cell growth and tumorigenesis, however, the interactive regulation and mechanism between these molecules are still elusive. In this study, by consecutive silencing of Aur A/B or/and BRCA1/2 with specific shRNAs, we showed that, in BRCA2-deficient pancreatic cancer cell line Capan-1 and in ovarian cancer cell line OVCA433, Aur A/B and BRCA1/2 inversely regulated the expression of each other likely through proteasome-mediated proteolysis but not through gene transcription. Aur A/B and BRCA1/2 conversely regulated cell cycle progression mainly through control of p53 and cyclin A. Moreover, the disruption of Aur A/B blocked abnormal cytokinesis and decreased cell multinuclearity and chromosome tetraploidy, whereas the deprivation of BRCA1/2 promoted the abnormal cytokinesis and enhanced the cell multinuclearity and tetraploidy. Furthermore, we showed by animal assays that the depletion of Aur A/B inhibited tumor growth of both cell lines, while the knockdown of BRCA1/2 promoted the tumor growth. However, the concurrent silencing of Aur A/B and BRCA1/2 diminished the effects of these molecules on the regulation of cell cycle, cytokinesis, and tetraploidy, leading to the burdened tumor sizes similar to those induced by scrambled shRNA-treated control cells. In summary, our study revealed that the negative interplay between Aur A/B and BRCA1/2 inversely controls the cell proliferation, cell cycle progression, cell multinuclearity, and tetraploidization to modulate tumorigenesis

Blastic plasmacytoid dendritic cell neoplasm complicated with acute myeloid leukemia: a case report

Blastic plasmacytoid dendritic cell neoplasm （BPDCN） complicated with acute myeloid leukemia （AML） is a rare disease. In this article， we reported the diagnosis and treatment of one patient of BPDCN complicated with AML who presented with fever as the first symptom， aiming to enhance the diagnostic and therapeutic capability of clinicians for this disease. The male patient， aged 69 years old， was admitted to hospital due to fever for 1 week. He had no typical skin lesions. Morphological and cytological observation of bone marrow smear showed extremely active hyperplasia and tumor cells with specific immunophenotype. The diagnosis of BPDCN complicated with AML was confirmed. A low-intensity venetoclax-based chemotherapy regimen was recommended. However， the patient discontinued further treatment

Phosphorus recovery from anaerobically digested liquor of screenings

Phosphorus is a limited resource which is predicted to get exhausted at some point during the twenty-first century. However, it is present in wastewaters at concentrations that come close to supplying the nation’s annual requirements for fertiliser. Many papers have addressed the recovery of phosphorus as struvite (magnesium ammonium phosphate hexahydrate) from different types of waste while the most prominent usage of struvite is as a slow-release fertiliser, suitable as a replacement for chemical fertiliser, for agricultural application. In this study, screenings produced during the wastewater treatment process were anaerobically digested to obtain anaerobically digested liquor which was subsequently used for phosphorus recovery in the form of struvite. This was carried out at different concentrations of dry solids. The amount of struvite potential was calculated theoretically using molar ratio calculations of 1:1:1 (Mg:N:P). From the results, it was found that the digestate is high in phosphorus content and can be recovered up to 41%. For struvite yield, 0.27,kg of struvite can be recovered from each kg dry solids of screenings from 3% of dry solids. Screenings thus prove a valuable source of additional phosphorus which current disposal practices fail to exploit

Photochromic Fluorescent Probe Strategy for the Super-resolution Imaging of Biologically Important Biomarkers

Here, we report a β-galactosidase (β-Gal)-responsive photochromic fluorescent probe, NpG, that was designed to prebind to human serum albumin (HSA) to form the probe/protein hybrid, NpG@HSA. The formation of NpG@HSA led to an increase in fluorescence emission (520 nm) corresponding to the binding of the fluorescent naphthalimide unit with HSA. In addition, this enabled visualization of the spiropyran fluorescence emission in aqueous media. Our probe/protein hybrid approach afforded a unique imaging platform with enhanced cell permeability and solubility that was capable of visualizing the cellular uptake of NpG@HSA before its activation by β-Gal. The β-Gal-mediated cleavage of the galactose unit within the NpG@HSA hybrid resulted in the formation of NpM@HSA and an increase in red fluorescence emission (620 nm). The resultant merocyanine unit was then able to undergo photoisomerization (merocyanine ↔ spiropyran) to facilitate STORM (i.e., stochastic optical reconstruction microscopy) imaging with minimal phototoxicity and excellent photostability/reversibility. Using STORM, NpG@HSA was able to determine the subcellular distribution of β-Gal activity between cell lines with nanoscale precision. We believe that this system represents a versatile imaging platform for the design of photochromic fluorescent probes suitable for illuminating the precise location of disease-specific biomarkers in various cellular processes.</p

Intra- and Inter-Scanner Reliability of Voxel-Wise Whole-Brain Analytic Metrics for Resting State fMRI

As the multi-center studies with resting-state functional magnetic resonance imaging (RS-fMRI) have been more and more applied to neuropsychiatric studies, both intra- and inter-scanner reliability of RS-fMRI are becoming increasingly important. The amplitude of low frequency fluctuation (ALFF), regional homogeneity (ReHo), and degree centrality (DC) are 3 main RS-fMRI metrics in a way of voxel-wise whole-brain (VWWB) analysis. Although the intra-scanner reliability (i.e., test-retest reliability) of these metrics has been widely investigated, few studies has investigated their inter-scanner reliability. In the current study, 21 healthy young subjects were enrolled and scanned with blood oxygenation level dependent (BOLD) RS-fMRI in 3 visits (V1 – V3), with V1 and V2 scanned on a GE MR750 scanner and V3 on a Siemens Prisma. RS-fMRI data were collected under two conditions, eyes open (EO) and eyes closed (EC), each lasting 8 minutes. We firstly evaluated the intra- and inter-scanner reliability of ALFF, ReHo, and DC. Secondly, we measured systematic difference between two scanning visits of the same scanner as well as between two scanners. Thirdly, to account for the potential difference of intra- and inter-scanner local magnetic field inhomogeneity, we measured the difference of relative BOLD signal intensity to the mean BOLD signal intensity of the whole brain between each pair of visits. Last, we used percent amplitude of fluctuation (PerAF) to correct the difference induced by relative BOLD signal intensity. The inter-scanner reliability was much worse than intra-scanner reliability; Among the VWWB metrics, DC showed the worst (both for intra-scanner and inter-scanner comparisons). PerAF showed similar intra-scanner reliability with ALFF and the best reliability among all the 4 metrics. PerAF reduced the influence of BOLD signal intensity and hence increase the inter-scanner reliability of ALFF. For multi-center studies, inter-scanner reliability should be taken into account

Destructive effects on endothelial cells of grafts in cytomegalovirus DNA-positive patients after keratoplasty

AIM: To investigate corneal graft survival rate and endothelial cell density (ECD) loss after keratoplasty in cytomegalovirus (CMV) positive patients. METHODS: This was a retrospective cohort study. We analyzed the clinical data of patients who underwent viral DNA detection in aqueous humor/corneal tissue collected during keratoplasty from March 2015 to December 2018 at the Peking University Third Hospital, Beijing, China. To further evaluate the effect of CMV on graft survival rate and ECD loss, patients were divided into three groups: 1) CMV DNA positive (CMV+) group; 2) viral DNA negative (virus-) group, comprising virus- group eyes pairwise matched to eyes in the CMV+ group according to ocular comorbidities; 3) control group, comprising virus- group eyes without ocular comorbidities. The follow-up indicators including graft survival rate, ECD, ECD loss, and central corneal thickness (CCT), were analyzed by Tukey honestly significant difference (HSD) test. RESULTS: Each group included 29 cases. The graft survival rate in CMV+ group were lowest among the three groups (P=0.000). No significant difference in donor graft ECD was found among three groups (P=0.54). ECD in the CMV+ group was lower than the virus- group at 12 (P=0.009), and 24mo (P=0.002) after keratoplasties. Furthermore, ECD loss was higher in the CMV+ group than in the virus- group in the middle stage (6-12mo) post-keratoplasty (P=0.017), and significantly higher in the early stage (0-6mo) in the virus- group than in the control group (P=0.000). CONCLUSION: CMV reduces the graft survival rate and exerts persistent detrimental effects on the ECD after keratoplasty. The graft ECD loss associate with CMV infection mainly occurrs in the middle stage (6-12mo postoperatively), while ocular comorbidities mainly affects ECD in the early stage (0-6mo postoperatively)